|
Name |
Guaidiol
|
Molecular Formula | C15H26O2 | |
IUPAC Name* |
(1S,3aS,4S,7R,8aS)-1,4-dimethyl-7-prop-1-en-2-yl-2,3,3a,5,6,7,8,8a-octahydroazulene-1,4-diol
|
|
SMILES |
CC(=C)[C@@H]1CC[C@]([C@H]2CC[C@]([C@H]2C1)(C)O)(C)O
|
|
InChI |
InChI=1S/C15H26O2/c1-10(2)11-5-7-14(3,16)12-6-8-15(4,17)13(12)9-11/h11-13,16-17H,1,5-9H2,2-4H3/t11-,12+,13+,14+,15+/m1/s1
|
|
InChIKey |
RQHOQQOEZPFYTD-QTVXIADOSA-N
|
|
Synonyms |
guaidiol; Guaiadiol A; Guaidiol A; CHEMBL463902; CHEBI:176395; DTXSID601139947; (1S,3aS,4S,7R,8aS)-1,4-dimethyl-7-prop-1-en-2-yl-2,3,3a,5,6,7,8,8a-octahydroazulene-1,4-diol; (1S,3aS,4S,7R,8aS)-Decahydro-1,4-dimethyl-7-(1-methylethenyl)-1,4-azulenediol; 217817-10-2
|
|
CAS | 217817-10-2 | |
PubChem CID | 10633702 | |
ChEMBL ID | CHEMBL463902 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 238.37 | ALogp: | 2.7 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.684 |
Caco-2 Permeability: | -4.468 | MDCK Permeability: | 0.00001450 |
Pgp-inhibitor: | 0.046 | Pgp-substrate: | 0.011 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.523 | Plasma Protein Binding (PPB): | 60.92% |
Volume Distribution (VD): | 1.14 | Fu: | 34.11% |
CYP1A2-inhibitor: | 0.029 | CYP1A2-substrate: | 0.411 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.857 |
CYP2C9-inhibitor: | 0.024 | CYP2C9-substrate: | 0.115 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.197 |
CYP3A4-inhibitor: | 0.256 | CYP3A4-substrate: | 0.514 |
Clearance (CL): | 10.467 | Half-life (T1/2): | 0.268 |
hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.408 |
Drug-inuced Liver Injury (DILI): | 0.039 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.328 | Maximum Recommended Daily Dose: | 0.157 |
Skin Sensitization: | 0.833 | Carcinogencity: | 0.848 |
Eye Corrosion: | 0.984 | Eye Irritation: | 0.972 |
Respiratory Toxicity: | 0.966 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005066 | 1.000 | D0I2SD | 0.314 | ||||
ENC005497 | 1.000 | D00VZZ | 0.313 | ||||
ENC002124 | 0.607 | D06AEO | 0.303 | ||||
ENC001836 | 0.410 | D04GJN | 0.299 | ||||
ENC002222 | 0.397 | D0B4RU | 0.298 | ||||
ENC001079 | 0.387 | D0L2LS | 0.294 | ||||
ENC002289 | 0.373 | D0U3GL | 0.293 | ||||
ENC000411 | 0.370 | D0Z1XD | 0.293 | ||||
ENC005065 | 0.358 | D0Q6NZ | 0.291 | ||||
ENC003624 | 0.358 | D07QKN | 0.283 |